Acute Pancreatitis in a Patient With COVID-19 After the Resolution of Respiratory Symptoms. J Investig Med High Impact Case Rep 2021;9:23247096211024773
Date
06/17/2021Pubmed ID
34130536Pubmed Central ID
PMC8212371DOI
10.1177/23247096211024773Scopus ID
2-s2.0-85108247550 (requires institutional sign-in at Scopus site) 3 CitationsAbstract
The gastrointestinal (GI) involvement, including acute pancreatitis (AP) from the novel coronavirus disease-2019 (COVID-19), is increasingly being reported. Recent evidence suggests that the pathogenesis of COVID-19 is mediated by the angiotensin-converting enzyme 2 (ACE-2) receptors and transmembrane protease serine 2 (TMPRSS2) for "priming," which is highly expressed in the pancreas. To our knowledge, there is no other reported case of AP associated with COVID-19 after the respiratory symptoms are resolved. In this article, we present a patient with COVID-19, who came with intractable epigastric pain and resolved respiratory symptoms. A diagnosis of AP complicated with COVID-19 was made after laboratory and imaging workup, which was successfully managed conservatively.
Author List
Muhammad Abrar Jeelani H, Sheikh MM, Samuel SS, Omotosho YB, Sharko A, Albetar RAuthor
Muhammad Mubbashir Sheikh MD Assistant Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Abdominal PainAnti-Bacterial Agents
Humans
Leukocytosis
Lipase
Male
Pancreatitis
Tomography, X-Ray Computed
Young Adult
